You are about to leave a GSK website
You are about to leave a GSK website. By clicking this link, you will be taken to a website that is independent from GSK. The site you are linking to is not controlled or endorsed by GSK, and GSK is not responsible for its content.
Your patients may be concerned about affording their treatment. We have resources and support to help you provide them with answers to their questions.

ZEJULA Copay Program
The ZEJULA Copay Program can help eligible commercially insured patients with their out-of-pocket costs for ZEJULA.
Your patient is eligible for this program if:
You can help your patient and/or their caregiver enroll in the Copay Program through the button below or, if your patient signs up for Together with ZEJULA, our Patient Experience Center can assist.

Patients can view copay information with their mobile wallet
Remind your patients they can keep track of their copay information on their smartphone. With a mobile wallet, like Apple Pay or Google Wallet, they can:
Copay Program Terms & Conditions

The GSK Patient Assistance Program for ZEJULA
The GSK Patient Assistance Program for ZEJULA, managed by the GSK Patient Access Programs Foundation, is an independent, 501(c)(3) charitable foundation, non-commercial entity, separate from GSK.
The program does not constitute health insurance. Eligibility for the GSK Patient Assistance Program for ZEJULA can be found by visiting GSK Patient Assistance for Prescription Medicine | GSKPAF.
To see if they qualify for ZEJULA PAP, they have to enroll. They have two options for enrollment:

Support from nonprofit organizations
Independent Foundations offer various types of assistance such as help paying for:
Explore independent Foundations that may offer support to eligible individuals.
If you have any questions about the type of financial assistance available, please be sure to check directly with the independent Foundations. Eligibility criteria is determined by each independent foundation. Together with ZEJULA does not determine eligibility and does not guarantee foundations will offer assistance.

If your patient is about to start treatment with ZEJULA, we can provide a 30-day supply to get them going as they work through their coverage and cost-support options.
To be eligible for the Quick Start program, the patient must:

If you recently prescribed a mid-cycle dose reduction of ZEJULA for your patient, we can provide a 30-day supply of the new dose at no charge while the new prescription is sent to the pharmacy.
To be eligible for the Bridge program, the patient must:
To enroll your patient in either program, download this form and follow the instructions: